EMEA (Europe, Middle East and Africa) Lifestyle Drugs Market Report 2017

August 2017 | 111 pages | ID: E23855B7F4CEN
QYResearch

Abstracts

In this report, the EMEA Lifestyle Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Lifestyle Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Lifestyle Drugs market competition by top manufacturers/players, with Lifestyle Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Allergan
• BMS
• Eli Lilly
• Pfizer
• Acerus Pharmaceuticals
• Alkermes
• Amorepacific
• AndroScience
• Anterios
• AstraZeneca
• Avanir Pharmaceuticals
• Avolynt
• Celtaxsys
• Cerecor

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Tablets
• Capsules
• Injections

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Lifestyle Drugs for each application, including

• Depression
• Dermatology
• Sexual dysfunction
• Obesity

Contents

EMEA (Europe, Middle East and Africa) Lifestyle Drugs Market Report 2017

1 LIFESTYLE DRUGS OVERVIEW

1.1 Product Overview and Scope of Lifestyle Drugs
1.2 Classification of Lifestyle Drugs
  1.2.1 EMEA Lifestyle Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Lifestyle Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablets
  1.2.4 Capsules
  1.2.5 Injections
1.3 EMEA Lifestyle Drugs Market by Application/End Users
  1.3.1 EMEA Lifestyle Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Depression
  1.3.3 Dermatology
  1.3.4 Sexual dysfunction
  1.3.5 Obesity
1.4 EMEA Lifestyle Drugs Market by Region
  1.4.1 EMEA Lifestyle Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Lifestyle Drugs (2012-2022)
  1.5.1 EMEA Lifestyle Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Lifestyle Drugs Revenue and Growth Rate (2012-2022)

2 EMEA LIFESTYLE DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Lifestyle Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Lifestyle Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Lifestyle Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Lifestyle Drugs Sale Price by Players (2012-2017)
2.2 EMEA Lifestyle Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Lifestyle Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Lifestyle Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Lifestyle Drugs Sale Price by Type (2012-2017)
2.3 EMEA Lifestyle Drugs (Volume) by Application
2.4 EMEA Lifestyle Drugs (Volume and Value) by Region
  2.4.1 EMEA Lifestyle Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Lifestyle Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Lifestyle Drugs Sales Price by Region (2012-2017)

3 EUROPE LIFESTYLE DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Lifestyle Drugs Sales and Value (2012-2017)
  3.1.1 Europe Lifestyle Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Lifestyle Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Lifestyle Drugs Sales and Market Share by Type
3.3 Europe Lifestyle Drugs Sales and Market Share by Application
3.4 Europe Lifestyle Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Lifestyle Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Lifestyle Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Lifestyle Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Lifestyle Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Lifestyle Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Lifestyle Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Lifestyle Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Lifestyle Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST LIFESTYLE DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Lifestyle Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Lifestyle Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Lifestyle Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Lifestyle Drugs Sales and Market Share by Type
4.3 Middle East Lifestyle Drugs Sales and Market Share by Application
4.4 Middle East Lifestyle Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Lifestyle Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Lifestyle Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Lifestyle Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Lifestyle Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Lifestyle Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Lifestyle Drugs Sales and Growth Rate (2012-2017)

5 AFRICA LIFESTYLE DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Lifestyle Drugs Sales and Value (2012-2017)
  5.1.1 Africa Lifestyle Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Lifestyle Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Lifestyle Drugs Sales and Market Share by Type
5.3 Africa Lifestyle Drugs Sales and Market Share by Application
5.4 Africa Lifestyle Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Lifestyle Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Lifestyle Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Lifestyle Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Lifestyle Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Lifestyle Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Lifestyle Drugs Sales and Growth Rate (2012-2017)

6 EMEA LIFESTYLE DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Allergan
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lifestyle Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 BMS
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Lifestyle Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BMS Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Lifestyle Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Lifestyle Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Acerus Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Lifestyle Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Alkermes
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Lifestyle Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Alkermes Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amorepacific
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Lifestyle Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amorepacific Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AndroScience
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Lifestyle Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AndroScience Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Anterios
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Lifestyle Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Anterios Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Lifestyle Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Avanir Pharmaceuticals
6.12 Avolynt
6.13 Celtaxsys
6.14 Cerecor

7 LIFESTYLE DRUGS MANUFACTURING COST ANALYSIS

7.1 Lifestyle Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lifestyle Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lifestyle Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lifestyle Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA LIFESTYLE DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Lifestyle Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Lifestyle Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Lifestyle Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Lifestyle Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Lifestyle Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Lifestyle Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Lifestyle Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Lifestyle Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Lifestyle Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Lifestyle Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lifestyle Drugs
Figure EMEA Lifestyle Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Lifestyle Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablets Product Picture
Figure Capsules Product Picture
Figure Injections Product Picture
Figure EMEA Lifestyle Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Lifestyle Drugs by Application in 2016
Figure Depression Examples
Figure Dermatology Examples
Figure Sexual dysfunction Examples
Figure Obesity Examples
Figure EMEA Lifestyle Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Lifestyle Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Lifestyle Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Lifestyle Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Lifestyle Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Lifestyle Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Lifestyle Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Lifestyle Drugs Sales Share by Players (2012-2017)
Figure 2016 Lifestyle Drugs Sales Share by Players
Figure 2017 Lifestyle Drugs Sales Share by Players
Figure EMEA Lifestyle Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Lifestyle Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Lifestyle Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Lifestyle Drugs Revenue Share by Players
Table 2017 EMEA Lifestyle Drugs Revenue Share by Players
Table EMEA Lifestyle Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Lifestyle Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Lifestyle Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Lifestyle Drugs by Type (2012-2017)
Figure EMEA Lifestyle Drugs Sales Market Share by Type (2012-2017)
Table EMEA Lifestyle Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Lifestyle Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lifestyle Drugs by Type in 2016
Table EMEA Lifestyle Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Lifestyle Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Lifestyle Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Lifestyle Drugs by Application (2012-2017)
Figure EMEA Lifestyle Drugs Sales Market Share by Application in 2016
Table EMEA Lifestyle Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Lifestyle Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Lifestyle Drugs by Region (2012-2017)
Figure EMEA Lifestyle Drugs Sales Market Share in 2016
Table EMEA Lifestyle Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Lifestyle Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Lifestyle Drugs by Region (2012-2017)
Figure EMEA Lifestyle Drugs Revenue Market Share Regions in 2016
Table EMEA Lifestyle Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Lifestyle Drugs Revenue and Growth Rate (2012-2017)
Table Europe Lifestyle Drugs Sales (K Units) by Type (2012-2017)
Table Europe Lifestyle Drugs Market Share by Type (2012-2017)
Figure Europe Lifestyle Drugs Market Share by Type in 2016
Table Europe Lifestyle Drugs Sales (K Units) by Application (2012-2017)
Table Europe Lifestyle Drugs Market Share by Application (2012-2017)
Figure Europe Lifestyle Drugs Market Share by Application in 2016
Table Europe Lifestyle Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Lifestyle Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Lifestyle Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Lifestyle Drugs Sales Market Share by Countries in 2016
Table Europe Lifestyle Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Lifestyle Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Lifestyle Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Lifestyle Drugs Revenue Market Share by Countries in 2016
Figure Germany Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Lifestyle Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Lifestyle Drugs Market Share by Type (2012-2017)
Figure Middle East Lifestyle Drugs Market Share by Type (2012-2017)
Table Middle East Lifestyle Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Lifestyle Drugs Market Share by Applications (2012-2017)
Figure Middle East Lifestyle Drugs Sales Market Share by Application in 2016
Table Middle East Lifestyle Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Lifestyle Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Lifestyle Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Lifestyle Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Lifestyle Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Lifestyle Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Lifestyle Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Lifestyle Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Lifestyle Drugs Sales (K Units) by Type (2012-2017)
Table Africa Lifestyle Drugs Sales Market Share by Type (2012-2017)
Figure Africa Lifestyle Drugs Sales Market Share by Type (2012-2017)
Figure Africa Lifestyle Drugs Sales Market Share by Type in 2016
Table Africa Lifestyle Drugs Sales (K Units) by Application (2012-2017)
Table Africa Lifestyle Drugs Sales Market Share by Application (2012-2017)
Figure Africa Lifestyle Drugs Sales Market Share by Application (2012-2017)
Table Africa Lifestyle Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Lifestyle Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Lifestyle Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Lifestyle Drugs Sales Market Share by Countries in 2016
Table Africa Lifestyle Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Lifestyle Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Lifestyle Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Lifestyle Drugs Revenue Market Share by Countries in 2016
Figure South Africa Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Allergan Lifestyle Drugs Basic Information List
Table Allergan Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Allergan Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Allergan Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table BMS Lifestyle Drugs Basic Information List
Table BMS Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BMS Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure BMS Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure BMS Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Lifestyle Drugs Basic Information List
Table Eli Lilly Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Lifestyle Drugs Basic Information List
Table Pfizer Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Acerus Pharmaceuticals Lifestyle Drugs Basic Information List
Table Acerus Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acerus Pharmaceuticals Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Acerus Pharmaceuticals Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Acerus Pharmaceuticals Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Alkermes Lifestyle Drugs Basic Information List
Table Alkermes Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alkermes Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Alkermes Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Alkermes Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Amorepacific Lifestyle Drugs Basic Information List
Table Amorepacific Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amorepacific Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amorepacific Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Amorepacific Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table AndroScience Lifestyle Drugs Basic Information List
Table AndroScience Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AndroScience Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AndroScience Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure AndroScience Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Anterios Lifestyle Drugs Basic Information List
Table Anterios Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anterios Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Anterios Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure Anterios Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Lifestyle Drugs Basic Information List
Table AstraZeneca Lifestyle Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Lifestyle Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Lifestyle Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Lifestyle Drugs Revenue Market Share in EMEA (2012-2017)
Table Avanir Pharmaceuticals Lifestyle Drugs Basic Information List
Table Avolynt Lifestyle Drugs Basic Information List
Table Celtaxsys Lifestyle Drugs Basic Information List
Table Cerecor Lifestyle Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lifestyle Drugs
Figure Manufacturing Process Analysis of Lifestyle Drugs
Figure Lifestyle Drugs Industrial Chain Analysis
Table Raw Materials Sources of Lifestyle Drugs Major Manufacturers in 2016
Table Major Buyers of Lifestyle Drugs
Table Distributors/Traders List
Figure EMEA Lifestyle Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Lifestyle Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Lifestyle Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Lifestyle Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Lifestyle Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Lifestyle Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Lifestyle Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Lifestyle Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Lifestyle Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Lifestyle Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Lifestyle Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Lifestyle Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Lifestyle Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Lifestyle Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Lifestyle Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Lifestyle Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Lifestyle Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Lifestyle Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Lifestyle Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Lifestyle Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Lifestyle Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Lifestyle Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Lifestyle Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources